Evonik Industries is introducing new hydrogen peroxide and peracetic acid grades for drug, medical products, and cosmetics manufacturers. As the central point of production, Evonik’s site in Weißenstein, Austria is currently being certified according to GMP guidelines. To date, the site is certified according to ISO 9001, 14001, and 13485. Overall, Evonik Industries has hydrogen peroxide production capacities at 12 sites globally.

Brenntag Europe, Middle East, and Africa is Evonik's partner in many European countries for the marketing of hydrogen peroxide and peracetic acid product portfolios in the personal care and healthcare markets. Product marketing will be launched in the middle of the year, spanning a total of 25 countries in Europe. Headquartered in Mülheim an der Ruhr, Germany, Brenntag operates a global network with more than 490 locations in 72 countries. In 2014, the company, which has a global workforce of more than 13,500, generated sales of EUR 10.0 billion ($13.3 billion).

Source: Brenntag